GRMN
62
-3
TDC
75
4
AVGO
20
-5
ICE
59
-3
CSCO
63
2
CVS
48
3
T
50
3
MUR
43
3
L
62
2
KMX
58
3
EQR
54
-2
EQIX
60
-2
IP
70
2
K
53
2
DVN
16
3
AA
51
3
STI
47
-12
PCG
93
2
AZO
46
-3
IBM
54
4
GRMN
62
-3
TDC
75
4
AVGO
20
-5
ICE
59
-3
CSCO
63
2
CVS
48
3
T
50
3
MUR
43
3
L
62
2
KMX
58
3
EQR
54
-2
EQIX
60
-2
IP
70
2
K
53
2
DVN
16
3
AA
51
3
STI
47
-12
PCG
93
2
AZO
46
-3
IBM
54
4
Financhill
Back

MEI Pharma 10K Form

Sell
41

MEIP
MEI Pharma

Last Price:
2.83
Seasonality Move:
-4.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MEIP News And Ratings

See the #1 stock for the next 7 days that we like better than MEIP

MEIP Financial Statistics

Sales & Book Value

Annual Sales: $65.3M
Cash Flow: $-18M
Price / Cash Flow: 0
Annual Sales: $4.96
Price / Book: 0.58

Profitability

EPS (TTM): 2.67000
Net Income (TTM): $17.78M
Gross Margin: $40.7M
Return on Equity: 0%
Return on Assets: 0%

MEI Pharma Earnings Forecast

Key MEI Pharma Financial Ratios

  • The Gross Profit Margin over the past 20 years for MEIP is 100.01%.
  • The Selling, General & Administrative Expenses for MEIP have been equal to 35.68% of Gross Profit Margin.
  • The Research & Development expenses have been 25.36% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

MEI Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MEIP
CUSIP: 55279B
Website: meipharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 1.08
Forward P/E Ratio: 0

MEIP Technical Analysis vs Fundamental Analysis

Sell
41
MEI Pharma (MEIP) is a Sell

Is MEI Pharma a Buy or a Sell?

  • MEI Pharma stock is rated a Sell
    The current MEI Pharma [MEIP] share price is $2.80. The Score for MEIP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.